NEW YORK (GenomeWeb) – Genomic Vision today announced that it has signed an agreement with APG Bio to distribute Genomic Vision's products and services to life science researchers in China, Hong Kong, and Macau.

Bagneux, France-based Genomic Vision markets its DNA Molecular Combing technology for genetic research applications including gene editing. It also provides a variety of molecular diagnostic tests for breast, ovarian, and colorectal cancers.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.